Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.12 | N/A |
| PEG Ratio (TTM) | 0.11 | N/A |
| P/S Ratio (TTM) | 0.43 | N/A |
| P/B Ratio (TTM) | 0.36 | N/A |
| P/FCF Ratio (TTM) | 11.36 | N/A |
| Price to 5YR AVG Earnings Ratio | 6.24 | N/A |
| Price to 5YR AVG FCF Ratio | 2.33 | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.10% | N/A |
| ROE (TTM) | 1.09% | N/A |
| Net Profit Margin (TTM) | 1.26% | N/A |
| ROIC 5YR AVG | -2.10% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -165.13% | 131.22% | 54.97% |
| Revenue | 2.18% | -2.19% | -2.19% |
| Net Income | -174.74% | 131.49% | 55.72% |
| Cash Flow | 529.44% | -18.71% | 8.17% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.19 | N/A |
| Interest Coverage (TTM) | 1.13 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.80 | N/A |
| LTL to 5YR AVG FCF | 1.24 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.25% | N/A |